Cardiff Oncology CRDF
NASDAQ CRDF
$0.88 -0.03 (-3.15%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cardiff Oncology (CRDF) Exchange Rate Effect (2016 - 2017)

Cardiff Oncology (CRDF) posted Exchange Rate Effect of $16406.0 for Q4 2017, up 245.86% sequentially from -$11248.0 in Q3 2017, and up 483.23% YoY from $2813.0 in Q4 2016.

Cardiff Oncology (CRDF) Exchange Rate Effect (2016 - 2017) Analysis & Trends

Cardiff Oncology has reported Exchange Rate Effect for 2 years, with the latest figure at $16406.0 in Q4 2017.

  • Quarterly Exchange Rate Effect rose 483.23% year-over-year to $16406.0 in Q4 2017, while the trailing twelve-month figure through Sep 2018 was $16406.0 (up 225.06% YoY) and the FY2017 annual result came in at $7569.0, up 229.94% from the prior year.
  • Exchange Rate Effect climbed to $16406.0 in Q4 2017 per CRDF's latest filing, from -$11248.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $16406.0 in Q4 2017 and troughed at -$11248.0 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -3.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -300,000.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -2.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 19.84 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -2.45 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1.63 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -287,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cardiff Oncology 60.21 Mn 60.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2017 16,406.00
Dec 31, 2017 16,406.00
Sep 30, 2017 -11,248.00
Sep 30, 2017 -11,248.00
Jun 30, 2017 3,255.00
Jun 30, 2017 3,255.00
Mar 31, 2017 -844.00
Mar 31, 2017 -844.00
Dec 31, 2016 -4,281.00
Dec 31, 2016 -4,281.00
Sep 30, 2016 929.00
Sep 30, 2016 929.00
Jun 30, 2016 -2,439.00
Jun 30, 2016 -2,439.00
Mar 31, 2016 -34.00
Mar 31, 2016 -34.00